Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Barrett's esophagus

S E Attwood1

  • 1St. James's Hospital, Dublin, Ireland.

Current Opinion in General Surgery
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Barrett's esophagus, linked to acid reflux, is common and associated with rapid cancer growth. Antireflux surgery is more effective than medication, but ongoing monitoring is crucial for patients with dysplasia.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Letter: increasing incidence and prevalence of eosinophilic oesophagitis.

Alimentary pharmacology & therapeutics·2015
Same author

Long-term safety of proton pump inhibitor therapy assessed under controlled, randomised clinical trial conditions: data from the SOPRAN and LOTUS studies.

Alimentary pharmacology & therapeutics·2015
Same author

Cancer of Oesophagus or Gastricus - New Assessment of Technology of Endosonography (COGNATE): report of pragmatic randomised trial.

Health technology assessment (Winchester, England)·2013
Same author

Gastric exocrine and endocrine cell morphology under prolonged acid inhibition therapy: results of a 5-year follow-up in the LOTUS trial.

Alimentary pharmacology & therapeutics·2012
Same author

The fallacy of comparing surgeons with pilots in the search for safer surgical training.

The British journal of surgery·2011
Same author

Outcome of patients in laparoscopic training courses compared to standard patients.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland·2010
Same journal

Sensitivity versus cost effectiveness in postoperative follow-up for colorectal cancer.

Current opinion in general surgery·1994
Same journal

Adjuvant radiation for rectal cancer: when and with what?

Current opinion in general surgery·1994
Same journal

Screening for colorectal cancer.

Current opinion in general surgery·1994
Same journal

Colorectal.

Current opinion in general surgery·1994
Same journal

The management of acute respiratory failure.

Current opinion in general surgery·1994
Same journal

The place for curative surgical procedures in the treatment of sporadic and familial Zollinger-Ellison syndrome.

Current opinion in general surgery·1994
See all related articles

Area of Science:

  • Gastroenterology
  • Oncology
  • Esophageal Diseases

Background:

  • Barrett's esophagus is highly prevalent and linked to the fastest-growing cancer in the US: esophageal adenocarcinoma.
  • Gastroesophageal reflux disease (GERD) is the primary driver of Barrett's esophagus pathogenesis.
  • Duodenal juices may contribute to complications like stricture, ulceration, and malignant transformation.

Purpose of the Study:

  • To investigate the etiology and pathogenesis of Barrett's columnar-lined lower esophagus.
  • To evaluate treatment strategies for GERD and its complications in Barrett's esophagus.
  • To emphasize the importance of surveillance in managing Barrett's esophagus.

Main Methods:

  • Review of current research on Barrett's esophagus etiology and pathogenesis.

Related Experiment Videos

  • Analysis of treatment outcomes for medical (acid suppression) and surgical interventions.
  • Assessment of the role of duodenal juices, cigarettes, and alcohol.

    • Main Results:

    • GERD is the most significant factor in Barrett's esophagus development.
    • Antireflux surgery demonstrates superior efficacy compared to medical management.
    • Massive acid suppression doses are needed for gastric hypersecretion, with limited effect on other reflux components.
    • Regression of Barrett's esophagus is uncommon; continued surveillance is vital, especially for patients with dysplasia.

    Conclusions:

    • Effective management of Barrett's esophagus requires abolishing all forms of reflux.
    • Antireflux surgery is the preferred treatment modality.
    • Vigilant surveillance, including monitoring for dysplasia and DNA abnormalities, is essential for patient management.